Your browser doesn't support javascript.
loading
Carbazole-based semicarbazones and hydrazones as multifunctional anti-Alzheimer agents.
Patel, Kishan B; Patel, Dushyant V; Patel, Nirav R; Kanhed, Ashish M; Teli, Divya M; Gandhi, Bhumi; Shah, Bhavik S; Chaudhary, Bharat N; Prajapati, Navnit K; Patel, Kirti V; Yadav, Mange Ram.
Affiliation
  • Patel KB; Faculty of Pharmacy, The Maharaja Sayajirao University of Baroda, Vadodara, Gujarat, India.
  • Patel DV; Faculty of Pharmacy, The Maharaja Sayajirao University of Baroda, Vadodara, Gujarat, India.
  • Patel NR; Faculty of Pharmacy, The Maharaja Sayajirao University of Baroda, Vadodara, Gujarat, India.
  • Kanhed AM; Shobhaben Pratapbhai Patel - School of Pharmacy & Technology Management, SVKM's NMIMS University, Mumbai, India.
  • Teli DM; Department of Pharmaceutical Chemistry, L. M. College of Pharmacy, Navrangpura, Gujarat, India.
  • Gandhi B; Faculty of Pharmacy, The Maharaja Sayajirao University of Baroda, Vadodara, Gujarat, India.
  • Shah BS; Faculty of Pharmacy, The Maharaja Sayajirao University of Baroda, Vadodara, Gujarat, India.
  • Chaudhary BN; Faculty of Pharmacy, The Maharaja Sayajirao University of Baroda, Vadodara, Gujarat, India.
  • Prajapati NK; Faculty of Pharmacy, The Maharaja Sayajirao University of Baroda, Vadodara, Gujarat, India.
  • Patel KV; Faculty of Pharmacy, The Maharaja Sayajirao University of Baroda, Vadodara, Gujarat, India.
  • Yadav MR; Faculty of Pharmacy, The Maharaja Sayajirao University of Baroda, Vadodara, Gujarat, India.
J Biomol Struct Dyn ; 40(20): 10278-10299, 2022.
Article de En | MEDLINE | ID: mdl-34215173
ABSTRACT
With the aim to combat a multi-faceted neurodegenerative Alzheimer's disease (AD), a series of carbazole-based semicarbazide and hydrazide derivatives were designed, synthesized and assessed for their cholinesterase (ChE) inhibitory, antioxidant and biometal chelating activity. Among them, (E)-2-((9-ethyl-9H-carbazol-3-yl)methylene)-N-(pyridin-2-yl)hydrazinecarbothioamide (62) and (E)-2-((9-ethyl-9H-carbazol-3-yl)methylene)-N-(5-chloropyridin-2-yl)hydrazinecarbothioamide (63) emerged as the premier candidates with good ChE inhibitory activities (IC50 values of 1.37 µM and 1.18 µM for hAChE, IC50 values of 2.69 µM and 3.31 µM for EqBuChE, respectively). All the test compounds displayed excellent antioxidant activity (reduction percentage of DPPH values for compounds (62) and (63) were 85.67% and 84.49%, respectively at 100 µM concentration). Compounds (62) and (63) conferred specific copper ion chelating property in metal chelation study. Molecular docking studies of compounds (62) and (63) indicate strong interactions within the active sites of both the ChE enzymes. Besides that, these compounds also exhibited significant in silico drug-like pharmacokinetic properties. Thus, taken together, they can serve as a starting point in the designing of multifunctional ligands in pursuit of potential anti-AD agents that might further prevent the progression of ADs.Communicated by Ramaswamy H. Sarma.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Semicarbazones / Maladie d'Alzheimer Limites: Humans Langue: En Journal: J Biomol Struct Dyn Année: 2022 Type de document: Article Pays d'affiliation: Inde

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Semicarbazones / Maladie d'Alzheimer Limites: Humans Langue: En Journal: J Biomol Struct Dyn Année: 2022 Type de document: Article Pays d'affiliation: Inde